Silencing a brain receptor curbs cancer cachexia and boosts mouse survival

Source Summary

A KAIST research team developed an RNA-based therapeutic strategy that blocks a brain signal to prevent muscle loss in cancer cachexia. The approach extended survival in mouse models of the condition.